|
Index of reports
> Cases with Benign Hydatidiform Mole (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pregnyl (Chorionic Gonadotropin) where reactions include benign hydatidiform mole. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Pregnyl side effects in female
Reported by a physician from Japan on 2012-04-26
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Ovarian Torsion, Ovarian Hyperstimulation Syndrome, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gonal-F RFF PEN
Indication: Ovulation Disorder
Clomiphene Citrate
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-08
End date: 2011-02-12
Gonal-F RFF PEN
Indication: Polycystic Ovaries
Start date: 2011-02-14
End date: 2011-02-19
Pregnyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-20
End date: 2011-02-20
Possible Pregnyl side effects in female
Reported by a physician from Japan on 2012-04-20
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Ovarian Torsion, Ovarian Hyperstimulation Syndrome, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gonal-F RFF PEN
Indication: Ovulation Disorder
Gonal-F RFF PEN
Indication: Polycystic Ovaries
Start date: 2011-02-14
End date: 2011-02-19
Pregnyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-20
End date: 2011-02-20
Clomiphene Citrate
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-08
End date: 2011-02-12
Possible Pregnyl side effects in female
Reported by a physician from Japan on 2012-03-20
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Ovarian Torsion, Ovarian Hyperstimulation Syndrome, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gonal-F RFF PEN
Indication: Polycystic Ovaries
Start date: 2011-02-14
End date: 2011-02-19
Gonal-F RFF PEN
Indication: Ovulation Disorder
Pregnyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-20
End date: 2011-02-20
Clomifene
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-08
End date: 2011-02-12
Possible Pregnyl side effects in 26 year old female
Reported by a physician from Japan on 2012-03-05
Patient: 26 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Abortion Threatened, Hyperemesis Gravidarum, Maternal Exposure Before Pregnancy, Ovarian Hyperstimulation Syndrome, Ovarian Neoplasm, Abortion Induced, Haemorrhage in Pregnancy, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pregnyl
Dosage: 5000 iu;once;im
Indication: Ovulation Induction
Start date: 2011-02-20
End date: 2011-02-20
Gonal-F (Follitropin Alfa) (Follitropin Alfa)
Dosage: 75 iu;qd;sc
Indication: Ovulation Induction
Start date: 2011-02-14
End date: 2011-02-19
Other drugs received by patient: Clomiphene Citrate; Metformin Hydrochloride
Possible Pregnyl side effects in female
Reported by a physician from Japan on 2012-03-02
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Ovarian Torsion, Maternal Exposure During Pregnancy, Abortion Induced, Ovarian Hyperstimulation Syndrome, Benign Hydatidiform Mole
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pregnyl
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-20
End date: 2011-02-20
Gonal-F RFF PEN
Indication: Ovulation Disorder
Gonal-F RFF PEN
Indication: Polycystic Ovaries
Start date: 2011-02-14
End date: 2011-02-19
Clomifene
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-08
End date: 2011-02-12
|
